Literature DB >> 24115598

Mycobacterial phenolic glycolipids with a simplified lipid aglycone modulate cytokine levels through Toll-like receptor 2.

Hassan R H Elsaidi1, Daniel R Barreda, Christopher W Cairo, Todd L Lowary.   

Abstract

Phenolic glycolipids (PGLs) are virulence factors present in the cell walls of many pathogenic mycobacteria. PGLs have been implicated in various aspects of mycobacterial disease, but there are limited structure-activity data available for these molecules. We report here the preparation of seven synthetic PGL analogues, differing from the native compounds in the replacement of the complex phenolic lipid moiety with a p-methoxyphenyl group. The ability of these compounds to stimulate or inhibit the production of cytokines (TNF-α, IL-1β, IL-6, MCP-1) and nitric oxide (NO) was then evaluated by ELISA-based assays. None of the compounds stimulated the production of these biological signalling molecules. In contrast, they each displayed concentration-dependent inhibitory activity, related to the methylation pattern of the molecule and mediated by Toll-like receptor 2. Additional studies revealed that native PGL-I from Mycobacterium leprae and a synthetic PGL-I analogue containing a simplified lipid domain had enhanced inhibitory activities relative to the corresponding analogues containing the p-methoxyphenyl aglycone; however, the natural lipid phenolthiocerol was only weakly active. These studies reveal that synthetic molecules of this type can be used as probes for PGL function. Moreover, their ease of synthesis relative to the natural glycolipids, as well as their more favourable aqueous solubility, should allow for more thorough structure-activity relationship studies.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Toll-like receptors; cytokines; immunochemistry; leprosy; mycobacteria

Mesh:

Substances:

Year:  2013        PMID: 24115598     DOI: 10.1002/cbic.201300505

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  6 in total

1.  Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2.

Authors:  Linh Nguyen; Kelli A McCord; Duong T Bui; Kim M Bouwman; Elena N Kitova; Mohamed Elaish; Dhanraj Kumawat; Gour C Daskhan; Ilhan Tomris; Ling Han; Pradeep Chopra; Tzu-Jing Yang; Steven D Willows; Andrew L Mason; Lara K Mahal; Todd L Lowary; Lori J West; Shang-Te Danny Hsu; Tom Hobman; Stephen M Tompkins; Geert-Jan Boons; Robert P de Vries; Matthew S Macauley; John S Klassen
Journal:  Nat Chem Biol       Date:  2021-11-09       Impact factor: 15.040

2.  Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids.

Authors:  Ainhoa Arbues; GeanCarlo Lugo-Villarino; Olivier Neyrolles; Christophe Guilhot; Catherine Astarie-Dequeker
Journal:  Front Cell Infect Microbiol       Date:  2014-12-09       Impact factor: 5.293

3.  Mycobacterial Phenolic Glycolipids Selectively Disable TRIF-Dependent TLR4 Signaling in Macrophages.

Authors:  Reid Oldenburg; Veronique Mayau; Jacques Prandi; Ainhoa Arbues; Catherine Astarie-Dequeker; Christophe Guilhot; Catherine Werts; Nathalie Winter; Caroline Demangel
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

4.  Effect of phenolic glycolipids from Mycobacterium kansasii on proinflammatory cytokine release. A structure-activity relationship study.

Authors:  Hassan R H Elsaidi; Todd L Lowary
Journal:  Chem Sci       Date:  2015-03-26       Impact factor: 9.825

5.  Synthetic Phenolic Glycolipids for Application in Diagnostic Tests for Leprosy.

Authors:  J Hessel M van Dijk; Anouk van Hooij; L Melanie Groot; Jolijn Geboers; Rosita Moretti; Els Verhard-Seymonsbergen; Danielle de Jong; Gijs A van der Marel; Paul L A M Corstjens; Jeroen D C Codée; Annemieke Geluk
Journal:  Chembiochem       Date:  2021-02-10       Impact factor: 3.164

6.  Twenty Years of Mycobacterial Glycans: Furanosides and Beyond.

Authors:  Todd L Lowary
Journal:  Acc Chem Res       Date:  2016-06-13       Impact factor: 22.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.